Professor Maekawa is a leading expert in clinical laboratory medicine in Japan. He is one of the researchers who set the guidelines for the quality assurance of clinical tests in Japan. He has been sharing his research results from Hamamatsu for over 20 years. Furthermore, in June 2022, he published the results of a prospective study on the immune response of the SARS-CoV-2 vaccine in the journal, Vaccines (https://doi.org/10.3390/vaccines10071050).